Literature DB >> 29202445

Balancing the benefits and harms of thyroid cancer surveillance in survivors of Childhood, adolescent and young adult cancer: Recommendations from the international Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium.

S C Clement1, L C M Kremer2, F A Verburg3, J H Simmons4, M Goldfarb5, R P Peeters6, E K Alexander7, E Bardi8, E Brignardello9, L S Constine10, C A Dinauer11, V M Drozd12, F Felicetti9, E Frey13, A Heinzel14, M M van den Heuvel-Eibrink15, S A Huang16, T P Links17, K Lorenz18, R L Mulder2, S J Neggers19, E J M Nieveen van Dijkum20, K C Oeffinger21, R R van Rijn22, S A Rivkees23, C M Ronckers2, A B Schneider24, R Skinner25, J D Wasserman26, T Wynn27, M M Hudson28, P C Nathan29, H M van Santen30.   

Abstract

Radiation exposure to the thyroid gland during treatment of childhood, adolescent and young adult cancer (CAYAC) may cause differentiated thyroid cancer (DTC). Surveillance recommendations for DTC vary considerably, causing uncertainty about optimum screening practices. The International Late Effects of Childhood Cancer Guideline Harmonization Group, in collaboration with the PanCareSurFup Consortium, developed consensus recommendations for thyroid cancer surveillance in CAYAC survivors. These recommendations were developed by an international multidisciplinary panel that included 33 experts in relevant medical specialties who used a consistent and transparent process. Recommendations were graded according to the strength of underlying evidence and potential benefit gained by early detection and appropriate management. Of the two available surveillance strategies, thyroid ultrasound and neck palpation, neither was shown to be superior. Consequently, a decision aid was formulated to guide the health care provider in counseling the survivor. The recommendations highlight the need for shared decision making regarding whether to undergo surveillance for DTC and in the choice of surveillance modality.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Childhood cancer/malignancy; Late/adverse effects; Surveillance; Survivors; Thyroid cancer/neoplasm

Mesh:

Year:  2017        PMID: 29202445     DOI: 10.1016/j.ctrv.2017.11.005

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


  17 in total

1.  Epidemiology of Thyroid Cancer.

Authors:  Cari M Kitahara; Arthur B Schneider
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-07-01       Impact factor: 4.090

2.  Polygenic Risk Score Improves Risk Stratification and Prediction of Subsequent Thyroid Cancer after Childhood Cancer.

Authors:  Nan Song; Qi Liu; Yutaka Yasui; Zhaoming Wang; Carmen L Wilson; Yadav Sapkota; Matthew J Ehrhardt; Todd M Gibson; Lindsay M Morton; Stephen J Chanock; Joseph P Neglia; Michael A Arnold; J Robert Michael; Alexander M Gout; Heather L Mulder; John Easton; Smita Bhatia; Gregory T Armstrong; Jinghui Zhang; Angela Delaney; Melissa M Hudson; Leslie L Robison
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-08-31       Impact factor: 4.090

3.  Identifying causal relationships of cancer treatment and long-term health effects among 5-year survivors of childhood cancer in Southern Sweden.

Authors:  Anders Holst; Jan Ekman; Magnus Petersson-Ahrholt; Thomas Relander; Thomas Wiebe; Helena M Linge
Journal:  Commun Med (Lond)       Date:  2022-03-02

4.  Subsequent Primary Cancer Risk Among 5-Year Survivors of Adolescent and Young Adult Cancers.

Authors:  Hyuna Sung; Rebecca L Siegel; Noorie Hyun; Kimberly D Miller; K Robin Yabroff; Ahmedin Jemal
Journal:  J Natl Cancer Inst       Date:  2022-08-08       Impact factor: 11.816

Review 5.  Consequences of atmospheric contamination by radioiodine: the Chernobyl and Fukushima accidents.

Authors:  C Ory; S Leboulleux; D Salvatore; B Le Guen; F De Vathaire; S Chevillard; M Schlumberger
Journal:  Endocrine       Date:  2020-10-06       Impact factor: 3.633

6.  Among Individuals Irradiated for Benign Conditions in Childhood, Developing Thyroid Cancer Does Not Affect All-Cause Survival.

Authors:  Leonid Vydro; Cari M Kitahara; Jay H Lubin; Arthur B Schneider; Dan V Mihailescu
Journal:  Thyroid       Date:  2020-01-16       Impact factor: 6.568

Review 7.  [Late effects following childhood cancer treatment : A special challenge for transition medicine].

Authors:  J Gebauer; H Lehnert; S M Schmid; C Spix; A Stein; T Langer
Journal:  Internist (Berl)       Date:  2018-11       Impact factor: 0.743

8.  Incidence of and Risk Factors for Histologically Confirmed Solid Benign Tumors Among Long-term Survivors of Childhood Cancer.

Authors:  Judith L Kok; Jop C Teepen; Helena J van der Pal; Flora E van Leeuwen; Wim J E Tissing; Sebastian J C M M Neggers; Jacqueline J Loonen; Marloes Louwerens; Birgitta Versluys; Marry M van den Heuvel-Eibrink; Eline van Dulmen-den Broeder; Monique M W Jaspers; Hanneke M van Santen; Margriet van der Heiden-van der Loo; Geert O Janssens; John H Maduro; Annette H Bruggink; Marjolijn C Jongmans; Leontien C M Kremer; Cécile M Ronckers
Journal:  JAMA Oncol       Date:  2019-05-01       Impact factor: 31.777

9.  Communicating with residents about 10 years of scientific progress in understanding thyroid cancer risk in children after the Fukushima Dai-ichi Nuclear Power Station accident.

Authors:  Gen Suzuki
Journal:  J Radiat Res       Date:  2021-05-05       Impact factor: 2.724

Review 10.  Recommendations on Surveillance for Differentiated Thyroid Carcinoma in Children with PTEN Hamartoma Tumor Syndrome.

Authors:  L A Jonker; C A Lebbink; M C J Jongmans; R A J Nievelstein; J H M Merks; E J M Nieveen van Dijkum; T P Links; N Hoogerbrugge; A S P van Trotsenburg; H M van Santen
Journal:  Eur Thyroid J       Date:  2020-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.